CVS Health's Aetna division is streamlining its preapproval process by bundling multiple cancer-related prior authorizations into a single request. The initiative, which launched for Medicaid members in eight states in September 2026 and expands to commercial and Medicare plans in 2027, aims to reduce the average of four separate approvals previously required per patient. While rivals like UnitedHealthcare and Humana are also cutting preapprovals, healthcare providers remain skeptical that these voluntary reforms will significantly ease administrative burdens or prevent treatment delays.
Aetna cancer prior authorization bundling
- ▪CVS Health's Aetna division is combining multiple preapproval requirements for cancer care into a single unified prior authorization request
- ▪Aetna's unified cancer care bundle combines separate prior authorizations for chemotherapy, immunotherapy, radiation oncology, and associated imaging like MRI or CT scans
- ▪Prior to Aetna's cancer prior authorization bundling program launched for Medicaid members in eight states in September 2026, healthcare providers submitted an average of four separate prior authorizations for each Aetna member undergoing cancer treatment
- ▪Aetna's cancer care bundling program launched for Medicaid members in September 2026 builds on a pilot from the summer of 2025 that combined authorizations for lung, breast, and prostate cancer
Administrative burden on providers
- ▪Healthcare providers contend that prior authorization processes contribute to clinician burnout, delay medical care, and can lead to worse patient health outcomes
- ▪A CVS-sponsored survey found that 74% of healthcare providers identified administrative burden as a top challenge, with 31% citing prior authorizations as the largest contributing factor to that administrative burden
Industry-wide prior authorization reform
- ▪UnitedHealthcare announced plans to eliminate approximately 30% of its prior authorization requirements, including removing preapprovals for roughly 1,700 medical codes starting in the fall of 2026
- ▪The insurance industry trade group AHIP led industry-wide commitments in 2025 to reduce medical services requiring approval, standardize electronic submissions, and speed up responses
- ▪Humana has pledged to eliminate 33% of its prior authorization requirements for outpatient services
Phased rollout across insurance lines
- ▪Aetna launched its bundled cancer care prior authorization process for Medicaid members in eight states, including Oklahoma, Illinois, Maryland, New Jersey, Virginia, Florida, Kentucky, and West Virginia, in September 2026
- ▪Aetna plans to roll out the bundled cancer prior authorization process it launched for Medicaid members in September 2026 to its commercial and Medicare Advantage plans in the first half of 2027
Provider skepticism about reform
- ▪Hospitals and doctors remain generally wary of insurer promises to restrict utilization management, such as CVS Health's Aetna cancer prior authorization bundling, UnitedHealthcare's elimination of prior authorization requirements, and Humana's pledge to cut prior authorizations for outpatient services, expressing uncertainty that these changes will reduce administrative burden or improve timely care
- ▪Provider skepticism regarding prior authorization reform is compounded by evidence, cited in a recent KFF analysis, that the majority of prior authorization denials in government programs are ultimately overturned upon appeal
Prior authorization denial overturn rates
- ▪An analysis by the Kaiser Family Foundation found that health insurers denied at least 1 in 8 standard prior authorization requests in government programs in 2025
- ▪The high volume of overturned prior authorization appeals suggests to healthcare providers that the requested medical care should have been approved initially
Debatable claims
- ▪Voluntary insurer reforms will significantly reduce administrative burdens on healthcare providers
- ▪Health insurers should eliminate prior authorization requirements for cancer care
Story comments
Loading comments…